and cancer using ex vivo HIP and in vivo fusogen platforms. SC291 is their CD19‑targeted allogeneic CAR-T candidate which also received FDA Fast Track for r/r SLE, extrarenal lupus, and lupus ...

such as total hip arthroplasty and core decompression, for patients with SLE and femoral head osteonecrosis.

The first high-throughput analysis of DNA methylation changes in systemic lupus erythematosus (SLE), published in Genome Research, has revealed differences between monozygotic twins discordant for ...

Belimumab combined with standard therapy demonstrated significant improvements in mucocutaneous symptoms in patients with systemic lupus erythematosus (SLE) compared with placebo with standard ...